STOCK TITAN
  1. Home
  2. Sec-filings
  3. VOR
  4. [Form 3] Vor Biopharma Inc. Initial Statement of Beneficial Ownership

[Form 3] Vor Biopharma Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock VOR logo
Vor Biopharma Inc.

NASDAQ:VOR

VOR Rankings

#6537 Ranked by Market Cap
N/A Ranked by Dividends

VOR Latest News

Jul 18, 2025
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jul 17, 2025
Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer
Jul 10, 2025
Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer
Jul 1, 2025
Vor Bio Report Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jun 26, 2025
PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement

VOR Latest SEC Filings

Jul 18, 2025
[Form 4] Vor Biopharma Inc. Insider Trading Activity
Jul 18, 2025
[Form 4] Vor Biopharma Inc. Insider Trading Activity
Jul 18, 2025
[Form 3] Vor Biopharma Inc. Initial Statement of Beneficial Ownership
Jul 16, 2025
[144] Vor Biopharma Inc. SEC Filing
Jul 15, 2025
[144] Vor Biopharma Inc. SEC Filing

VOR Stock Data

288.66M
71.23M
32.03%
49.54%
1.17%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
CAMBRIDGE